ReviewCerebral circulation - cognition and behavior2025
Aging of neural stem cells and vascular dysfunction: mechanisms, interconnection, and therapeutic perspectives.
Review in Cerebral circulation - cognition and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Inflammaging and neurovascular unit dysfunction in cognitive ageing: mechanisms, biomarkers, and therapeutic opportunities.Frontiers in aging neuroscience · 2026Review
- Repair and regeneration across the lifespan: an ontogenetic perspective.Frontiers in aging · 2026Review
- Senotherapeutics for Brain Aging Management.Neurology international · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aging of the central nervous system is accompanied by a progressive decline in neuroplasticity, regenerative capacity, and vascular integrity. Neural stem cells (NSCs) and cerebral vasculature are both critically involved in maintaining homeostasis, and their age-related dysfunction contributes to neurodegenerative and cerebrovascular diseases. Objective: This article explores the mechanisms underlying NSC aging and vascular deterioration, their mutual interconnection, and the implications for brain health in aging populations. Methods: We review current evidence on molecular and cellular pathways affecting neurogenesis and cerebral perfusion, including dysregulation of BDNF, VEGF, mTOR, AMPK, and the effects of oxidative stress and chronic inflammation. We also highlight emerging biomarkers and therapeutic targets. Results: Aging disrupts the neurovascular unit, impairing both neurogenesis and vascular support systems. Chronic inflammation and oxidative stress exacerbate these processes, forming a self-perpetuating degenerative cycle. Antioxidant and anti-inflammatory therapies, along with stem cell-based interventions such as mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs), show promise for restoring neural and vascular function. Conclusion: Addressing both NSC and vascular aging is essential for developing effective interventions against cognitive decline and cerebrovascular pathology. Integrative and personalized therapeutic strategies targeting shared molecular pathways hold great promise for future clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.